CClinicalTrials.gg
RecruitingNCT05223192Updated Aug 13, 2026

The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants

An interventional study of Music Therapy Entrainment with Ocean Disc Intervention in Prematurity, sponsored by Icahn School of Medicine at Mount Sinai. Recruiting at 1 site in United States. Open to participants aged 24 Weeks to 37 Weeks. Per ClinicalTrials.gov, last updated 2026-08-13.

Sponsored by Icahn School of Medicine at Mount Sinai · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Started Apr 2022; still recruiting 4 years 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
24 Weeks to 37 Weeks
Sex
All
01

Study summary

Infants born prematurely at will be asked to participate in this randomized controlled trial at a corrected gestational age of 24-37 weeks. Infants will be randomly selected to each of the two groups: intervention and control. Infants in the treatment group will receive six intervention days over a two-week period, 3 sessions per week. Each intervention day consists of each of the two interventions in a random sequence: no intervention/silence and live ocean disc instrument intervention. The sound decibel level will also be recorded and maintained at 40-65dB to prevent overstimulation. Each infant will thus receive control and ocean disc intervention on the same day in the NICU. Interventions will be given in a randomized order (i.e., first ocean disc or first silence, randomized to AM or PM), with observation occurring for 10 minutes before each intervention, 15 minutes during each intervention, and 10 minutes after each per session. There will be 3 sessions per week for a two-week randomized treatment schedule. For each infant, data on total apnea time, mean respiratory rate, heart rate, O2 levels and behavior rating during will be collected. The sound decibel level will also be recorded and maintained at 40-65dB to prevent overstimulation and hearing damage. Near-infrared light spectroscopy (NIRS) data on cerebral oxygenation will also be collected. Observations will be recorded on the infant's activity or when change occurs, such as a pacifier falling out. Parents and nurses will be asked to behave as they normally would during routine care.

02

Conditions studied

  • Prematurity

Browse trials for

Keywords

  • music therapy
  • ocean disc
  • prematurity
  • vital signs
  • cerebral oxygenation
03

In context

Premature Birth

2,554 studies on the registry are indexed under Premature Birth; 498 are open to participants now.

This study's planned enrollment of 120 is above the median of 84 across 1,689 interventional studies indexed under Premature Birth.

Browse Premature Birth studies →

Lead sponsor

Icahn School of Medicine at Mount Sinai is the lead sponsor of 764 studies on the registry; 181 are open to participants now.

Of its 121 completed or terminated interventional studies of FDA-regulated products, 82 (68%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
24 Weeks to 37 Weeks
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Newborns born at 24-37 weeks' gestation at Mount Sinai hospital
  • Newborn is considered appropriate for clinically indicated music therapy

Exclusion criteria

Exclusion Criteria:

  • Infant not expected to survive 24 hours from the time of study entry (To be assessed by a member of the NICU Faculty other than the PI)
  • Infant of uncertain viability (gestation \<23 weeks, birth weight \<500 grams)
  • Known or suspected genetic disorder (e.g., Trisomy 21)
  • Identified hearing disorder
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    Intervention group

    Participants in this group will receive the ocean disc music therapy entrainment intervention

    Behavioral: Music Therapy Entrainment with Ocean Disc Intervention

  • No intervention
    Control group

    Participants in this group will not receive any intervention

Interventions

  • BehavioralMusic Therapy Entrainment with Ocean Disc Intervention

    The studied intervention regards live entrainment with the ocean disc. Entrainment involves the use of an external stimulus, in the case of this study, an ocean disc instrument. Motion of the disc creates sounds in synchrony with the breathing of the infant and then in turn can control and influence the infant's regulation of the breath.

06

What researchers measure

Primary outcomes

  1. Heart Rate

    Time frame: 14 days

  2. Respiratory Rate

    Time frame: 14 days

  3. Oxygen-Saturation Level

    Time frame: 14 days

  4. Weight

    Time frame: 14 days

  5. Cerebral oxygen saturation

    Cerebral oxygen saturation measured using NIRS

    Time frame: 14 days

07

Study locations

1 of 1 sites recruiting
  • Mount Sinai Hospitals
    New York, New York 10003, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — IPD will be made available upon reasonable request to corresponding author

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05223192
Lead sponsor
Icahn School of Medicine at Mount Sinai
Responsible party
Joanne Loewy (Associate Clinical Professor, Icahn School of Medicine at Mount Sinai) — Principal investigator
First posted
Feb 3, 2022
Start date
Apr 1, 2022
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Aug 13, 2026

Study contacts

Joanne V Loewy, DA, MT-BC, LCAT
Contact
joanne.loewy@mountsinai.org
(212) 420-3484
Elizabeth Barone
Contact
Elizabeth.Barone@mountsinai.org
212 420-2704
Joanne V Loewy, DA, MT-BC, LCAT
principal investigator · Icahn School of Medicine at Mount Sinai

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion